A reappraisal of the therapeutic effect of suberoylanilide hydroxamic acid in HD model mice revealed that it reduced HDAC4 level through increased degradation.62 Understanding and modulating the noncatalytic functions of HDAC4 is a focus of current study. Here, HDAC4 is linked to Huntington disease.